Bulletin Updates

Pharma company faces rating changes post-amalgamation – 13 Mar 2024

Mar 13, 2024

In an effort to increase its profitability and business diversification, a pharmaceutical company with a significant export presence in regulated countries is merging with another business

The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »